SAN MATEO, CA -- (MARKET WIRE) -- September 25, 2006 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) announced that Friedhelm Blobel, Ph.D., SciClone’s recently appointed President and Chief Executive Officer, will unveil a focused global strategic vision and upcoming milestones during his presentation at the UBS Global Life Sciences Conference at 9:30 am EDT today. To access the live audio webcast of the presentation, log on through a link located in the Investor Relations section of SciClone’s website at www.sciclone.com. A replay of the webcast will be available until October 25, 2006.
